Understand the source comparison
SS-LUP-332 Research Log Track Document: Study Design Comparison
Dosing Frequency Daily (0.5–1.0 mg/kg) Every 48 hours (1.5–2.0 mg/kg) Protocol-matched to primary site Short-term studies require higher frequency to maintain steady-state REV-ERB activation; longer protocols leverage the compound's multi-day receptor occupanc
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dosing Frequency
- Daily (0.5–1.0 mg/kg)
- Every 48 hours (1.5–2.0 mg/kg)
- Protocol-matched to primary site
- Short-term studies require higher frequency to maintain steady-state REV-ERB activation; longer protocols leverage the compound's multi-day receptor occupancy
- Temperature Monitoring
- Twice-daily manual checks
- Continuous datalogger with cloud sync
- Centralized monitoring dashboard
- Manual logging suffices for single-lab studies; multi-site requires automated systems to detect cross-location storage inconsistencies
- Sample Storage
- −80°C within 30 minutes of collection
- −80°C within 15 minutes, backup liquid nitrogen
- Standardized aliquot volumes across sites
- Extended studies accumulate more samples. Faster processing prevents oxidative degradation that skews lipid panel results
- Documentation Backup
- Daily manual entry to spreadsheet
- Automated digital logs with audit trail
- Blockchain-verified timestamping (optional)
- Regulatory agencies increasingly require tamper-proof logs; paper records are acceptable but digitization prevents retroactive modification claims
- Deviation Threshold
- ±3-hour dosing window acceptable
- ±1-hour window to maintain circadian alignment
- Zero tolerance; deviations trigger protocol amendment
- REV-ERB agonists entrain circadian clocks. Timing precision matters more in chronic studies than acute bolus experiments